Impacts of the 2016 Kumamoto Earthquake on glycemic control in patients with diabetes.


Journal

Journal of diabetes investigation
ISSN: 2040-1124
Titre abrégé: J Diabetes Investig
Pays: Japan
ID NLM: 101520702

Informations de publication

Date de publication:
Mar 2019
Historique:
received: 07 05 2018
revised: 19 06 2018
accepted: 03 07 2018
pubmed: 7 7 2018
medline: 10 7 2019
entrez: 7 7 2018
Statut: ppublish

Résumé

On April 14 and 16 2016, the Kumamoto area was severely damaged by several massive magnitude 7 class earthquakes. To examine the effects of these earthquakes on glycemic control and stress factors, glycated hemoglobin, glycated albumin, other biochemical parameters, a self-administered lifestyle-associated questionnaire and disaster-associated stress scores were analyzed. A total of 557 patients with diabetes were enrolled, and data were collected at 13 months before to 13 months after the earthquakes. In patients with type 1 diabetes and specific types of diabetes due to other causes, glycemic control was not altered during the observational period. This glycemic stability in type 1 diabetes might result from self-management of insulin doses. In patients with type 2 diabetes, glycated hemoglobin decreased by 0.11% (from 7.33 to 7.22%) at 1-2 months after the earthquakes, and increased thereafter. The reduction of glycated hemoglobin after 1-2 months in type 2 diabetes was associated with 'early restoration of lifelines' and 'sufficient sleep.' The glycemic deterioration at a later stage was related to 'shortage of antidiabetic agents,' 'insufficient amount of food,' 'largely destroyed houses' and 'changes in working environments.' Disaster-associated stress levels were positively correlated with 'age,' 'delayed restoration of lifelines,' 'self-management of antidiabetic agents' and 'increased amount of physical activity/exercise,' and negatively associated with 'early restoration of lifelines' and 'sufficient sleep.' Glycemic control, associated factors and stress levels are altered in chronological order. Post-disaster diabetic medical care must consider these corresponding points in accordance with the time-period.

Identifiants

pubmed: 29978571
doi: 10.1111/jdi.12891
pmc: PMC6400205
doi:

Substances chimiques

Biomarkers 0
Blood Glucose 0
Glycated Hemoglobin A 0
Hypoglycemic Agents 0
hemoglobin A1c protein, human 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

521-530

Subventions

Organisme : NPO Blue Circle 2050

Informations de copyright

© 2018 The Authors. Journal of Diabetes Investigation published by Asian Association for the Study of Diabetes (AASD) and John Wiley & Sons Australia, Ltd.

Références

Diabet Med. 2012 Nov;29(11):1451-5
pubmed: 22416679
J Nerv Ment Dis. 2002 Mar;190(3):175-82
pubmed: 11923652
Arch Intern Med. 1998 Feb 9;158(3):274-8
pubmed: 9472208
Proc Jpn Acad Ser B Phys Biol Sci. 2016;92(8):358-371
pubmed: 27725474
Endocr J. 2004 Aug;51(4):407-14
pubmed: 15351797
Diabetes Res Clin Pract. 1997 Jun;36(3):193-6
pubmed: 9237786
Arch Environ Health. 2000 Mar-Apr;55(2):121-5
pubmed: 10821513
Diabetes Care. 2007 Sep;30(9):2395-8
pubmed: 17623820
Intern Med. 1997 Feb;36(2):87-91
pubmed: 9099588
Obes Rev. 2017 Feb;18 Suppl 1:15-24
pubmed: 28164449
Diabetes Res Clin Pract. 2006 Nov;74(2):141-7
pubmed: 16723162
J Diabetes Investig. 2015 Sep;6(5):577-86
pubmed: 26417417
Diabetes Care. 2014 Oct;37(10):e212-3
pubmed: 25249676
J Diabetes Investig. 2019 Mar;10(2):521-530
pubmed: 29978571

Auteurs

Tatsuya Kondo (T)

Department of Metabolic Medicine, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan.

Nobukazu Miyakawa (N)

Department of Metabolic Medicine, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan.

Hiroyuki Motoshima (H)

Department of Metabolic Medicine, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan.

Satoko Hanatani (S)

Department of Metabolic Medicine, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan.

Norio Ishii (N)

Department of Metabolic Medicine, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan.

Motoyuki Igata (M)

Department of Metabolic Medicine, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan.

Kayo Yoshinaga (K)

Department of Metabolic Medicine, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan.

Daisuke Kukidome (D)

Department of Metabolic Medicine, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan.

Takafumi Senokuchi (T)

Department of Metabolic Medicine, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan.

Junji Kawashima (J)

Department of Metabolic Medicine, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan.

Noboru Furukawa (N)

Department of Metabolic Medicine, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan.

Takeshi Matsumura (T)

Department of Metabolic Medicine, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan.

Eiichi Araki (E)

Department of Metabolic Medicine, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH